Literature DB >> 22865545

Unchanged prevalence of Down syndrome in the Netherlands: results from an 11-year nationwide birth cohort.

Helma B M van Gameren-Oosterom1, S E Buitendijk, C M Bilardo, Karin M van der Pal-de Bruin, J P Van Wouwe, A D Mohangoo.   

Abstract

OBJECTIVE: This study aims to evaluate trends in prevalence of Down syndrome (DS) births in the Netherlands over an 11-year period and how they have been affected by maternal age and introduction of prenatal screening.
METHOD: Nationwide data of an 11-year birth cohort (1997-2007) from the Netherlands Perinatal Registry were analyzed. First-trimester combined screening was introduced in 2002, free of charge only for women 36 years of age or older and only on patients' request. Changes in maternal age, prevalence of DS births, and rates of births at <24 weeks (legal limit for termination of pregnancy in the Netherlands) during the study period were evaluated using logistic and linear regression analyses.
RESULTS: In total, 1,972,058 births were registered (91% of the births in 1997-2007). Mean prevalence of DS was 14.57 per 10,000 births (95% confidence interval 14.43; 14.73); 85% of DS were live births. No significant trend in overall prevalence of DS births was observed (p = 0.385), in spite of a significant increase of mean maternal age during the same period (p < 0.001). The increased prevalence of DS births at ≥ 24 weeks among women ≥ 36 years of age (p = 0.011) was offset by a significant increase in the proportion of DS births at <24 weeks among women aged <36 years (p = 0.013).
CONCLUSION: The proportion of DS births in the Netherlands has not changed during the period 1997-2007.
© 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22865545     DOI: 10.1002/pd.3951

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

1.  Mainstream and special school attendance among a Dutch cohort of children with Down Syndrome.

Authors:  Jacobus P van Wouwe; Helma B M van Gameren-Oosterom; Paul H Verkerk; Paula van Dommelen; Minne Fekkes
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

2.  Combined first-trimester screening in northern Finland: experiences of the first ten years.

Authors:  Anna Merilainen; Sini Peuhkurinen; Timppa Honkasalo; Paivi Laitinen; Hannaleena Kokkonen; Markku Ryynanen; Jaana Marttala
Journal:  Clin Med Insights Reprod Health       Date:  2014-07-30

3.  Pain in Intellectually Disabled Children: Towards Evidence-Based Pharmacotherapy?

Authors:  Abraham J Valkenburg; Tom G de Leeuw; Monique van Dijk; Dick Tibboel
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

Review 4.  Systematic review and meta-analysis shows a specific micronutrient profile in people with Down Syndrome: Lower blood calcium, selenium and zinc, higher red blood cell copper and zinc, and higher salivary calcium and sodium.

Authors:  Amene Saghazadeh; Maryam Mahmoudi; Atefeh Dehghani Ashkezari; Nooshin Oliaie Rezaie; Nima Rezaei
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

Review 5.  In search of quality indicators for Down syndrome healthcare: a scoping review.

Authors:  Francine A van den Driessen Mareeuw; Mirjam I Hollegien; Antonia M W Coppus; Diana M J Delnoij; Esther de Vries
Journal:  BMC Health Serv Res       Date:  2017-04-18       Impact factor: 2.655

6.  Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000-2013.

Authors:  Maurike D de Groot-van der Mooren; Saskia Tamminga; Dick Oepkes; Michel E Weijerman; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2018-01-12       Impact factor: 4.246

7.  Effects of bifocals on visual acuity in children with Down syndrome: a randomized controlled trial.

Authors:  Christine de Weger; Nienke Boonstra; Jeroen Goossens
Journal:  Acta Ophthalmol       Date:  2018-10-27       Impact factor: 3.761

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.